Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) — Net Asset Quality Index
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) has a Net Asset Quality Index of 25.1% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥6.39 Billion minus total liabilities of CN¥4.79 Billion yields net assets of CN¥1.60 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Hunan Dajiaweikang Pharmaceutical Indust (301126) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Net Asset Quality Index Over Time (2019–2025)
This chart shows how Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's Net Asset Quality Index has evolved across 7 annual periods from 2019 to 2025. As of March 2026, the index stands at 25.1%, representing net assets of CN¥1.60 Billion against total assets of CN¥6.39 Billion CNY. See working capital position of Hunan Dajiaweikang Pharmaceutical Indust to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (2019–2025)
The table below presents the year-by-year Net Asset Quality Index for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd from 2019 to 2025, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 301126 market cap.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 25.1% | CN¥1.59 Billion | CN¥6.34 Billion | CN¥4.74 Billion | ▼ -4.8 pp |
| 2024 | 29.9% | CN¥1.85 Billion | CN¥6.18 Billion | CN¥4.33 Billion | ▼ -3.8 pp |
| 2023 | 33.8% | CN¥1.78 Billion | CN¥5.28 Billion | CN¥3.50 Billion | ▼ -12.5 pp |
| 2022 | 46.2% | CN¥1.82 Billion | CN¥3.93 Billion | CN¥2.11 Billion | ▼ -9.9 pp |
| 2021 | 56.1% | CN¥1.68 Billion | CN¥2.99 Billion | CN¥1.32 Billion | ▲ +8.8 pp |
| 2020 | 47.3% | CN¥1.04 Billion | CN¥2.20 Billion | CN¥1.16 Billion | ▼ -1.2 pp |
| 2019 | 48.5% | CN¥977.24 Million | CN¥2.02 Billion | CN¥1.04 Billion | — |